Menus Subscribe Search

Follow us


injection-needle

(PHOTO: JOLOEI/SHUTTERSTOCK)

The Cheaper, Bacteria-Derived Future of Drugs

• July 19, 2013 • 6:00 AM

(PHOTO: JOLOEI/SHUTTERSTOCK)

Drugs made from plants are often too expensive for the people who need them. A group of scientists may have found a solution.

The world is in dire need of cheap drugs to combat malaria. Malaria may seem like a disease from the distant past, but world-wide, it still exacts a large toll. Even worse, today’s malaria parasites are often resistant to the standard anti-malarial drugs. Newer and more effective drugs exist, but these drugs are well out of the price range of the patients in the developing world who need them.

Part of the problem is that the newer anti-malarial drugs come from plants. For thousands of years, humans have been getting their drugs from plants. While plants make a wide range of pharmacologically active compounds, they are not very practical: they can be difficult to cultivate in large quantities, their chemical yield can be unreliable, and the product we’re interested in can be expensive to isolate from other chemicals made by the plant. Add all that up and plant-derived drugs are too expensive for the people who need them. But there may be a solution: drugs made from bacteria (and other microbes).

Different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions.

The current source of newer anti-malarial drugs is Sweet Wormwood, a plant used in traditional Chinese medicine. The Chinese have long cultivated Sweet Wormwood, but the current world acreage of this plant is much less than we need. And even if there were enough Sweet Wormwood available, extracting the active ingredient, artemisinin, is an expensive and inefficient process.

To tackle this problem, the Bill and Melinda Gates Foundation funded a California-based group of industry and academic scientists to build a microbe that can crank out suitably large amounts of artemisinin (or artemisinic acid, a closely related chemical) while fermenting in an industrial-scale vat. The group recently reported success, which they achieved by making a variety of genetic modifications to ordinary baker’s yeast. The result is a yeast that makes artemisinic acid while fermenting sugar.

In the case of artemisinin-producing yeast, the researchers modified a natural yeast metabolic system, one that converts a chemical called Acetyl-CoA into a steroid. Acetyl-CoA is made by every organism on Earth, and is a precursor of many important biological molecules. The scientists made several genetic hacks to this metabolic system, resulting in a yeast strain whose enzyme levels can be fine-tuned by adding cheap chemicals to the yeasts’ nutrient broth. With the enzyme levels set just right, the yeasts’ Acetyl-CoA-to-steroid machinery gets highjacked to make large amounts of a chemical that is just a few enzymatic steps away from artemisinic acid.

The final genetic modification was to build in new enzymes that finish the job of making artemisinic acid. To do this, the researchers took a set of enzyme genes from Sweet Wormwood and transplanted them into the genome of their engineered yeast strain. The result: a yeast that feeds on sugar and pumps out artemisinic acid, at a fraction of the cost of extracting artemisinin from hectares of Sweet Wormwood.

The project involved substantial R&D, but principles can apply broadly. One reason why this kind of Wormwood-to-yeast metabolic engineering is successful is that the Wormwood enzymes involved are not very different from yeast enzymes that have other functions, making it possible for Wormwood enzymes to function in a yeast cell. In nature, there are many variations on a basic enzyme design; different versions of the same class of enzyme can carry out a mind-boggling range of chemical reactions. There is even a strain of bacteria (which evolved naturally in a contaminated military training range) whose enzymes break down explosives for food. The chemical repertoire of the natural world is tremendous. By harnessing that repertoire in microbial factories, we can make drugs, biofuels, and other chemicals in a way that has the potential to be cheaper, safer, and less damaging to the environment.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 20 • 4:00 PM

The Bird Hat Craze That Sparked a Preservation Movement

How a fashion statement at the turn of the 19th century led to the creation of the first Audubon societies.


October 20 • 2:00 PM

The Risk of Getting Killed by the Police If You Are White, and If You Are Black

An analysis of killings by police shows outsize risk for young black males.


October 20 • 12:00 PM

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they’re motivated by love while their enemies are motivated by hate.


October 20 • 11:00 AM

My Dog Comes First: The Importance of Pets to Homeless Youth

Dogs and cats have both advantages and disadvantages for street-involved youth.


October 20 • 10:00 AM

Homophobia Is Not a Thing of the Past

Despite growing support for LGBT rights and recent decisions from the Supreme Court regarding the legality of same-sex marriage, the battle for acceptance has not yet been decided.


October 20 • 8:00 AM

Big Boobs Matter Most

Medical mnemonics are often scandalous and sexist, but they help the student to both remember important facts and cope with challenging new experiences.


October 20 • 6:00 AM

When Disease Becomes Political: The Likely Electoral Fallout From Ebola

Will voters blame President Obama—and punish Democrats in the upcoming mid-term elections—for a climate of fear?


October 20 • 4:00 AM

Coming Soon: The Anatomy of Ignorance


October 17 • 4:00 PM

What All Military Families Need to Know About High-Cost Lenders

Lessons from over a year on the beat.


October 17 • 2:00 PM

The Majority of Languages Do Not Have Gendered Pronouns

A world without “he.” Or “she.”


October 17 • 11:01 AM

How to Water a Farm in Sandy Ground

Physicists investigate how to grow food more efficiently in fine-grained soil.


October 17 • 10:00 AM

Can Science Fiction Spur Science Innovation?

Without proper funding, the answer might not even matter.


October 17 • 8:00 AM

Seattle, the Incredible Shrinking City

Seattle is leading the way in the micro-housing movement as an affordable alternative to high-cost city living.


October 17 • 6:00 AM

‘Voodoo Death’ and How the Mind Harms the Body

Can an intense belief that you’re about to die actually kill you? Researchers are learning more about “voodoo death” and how it isn’t limited to superstitious, foreign cultures.


October 17 • 4:00 AM

That Arts Degree Is Paying Off

A survey of people who have earned degrees in the arts find they are doing relatively well, although their education didn’t provide much guidance on managing a career.


October 16 • 4:00 PM

How (Some) Economists Are Like Doomsday Cult Members

Cognitive dissonance and clinging to paradigms even in the face of accumulated anomalous facts.


October 16 • 2:00 PM

The Latest—and Most Mysterious—Player in the Nasty Battle Over Net Neutrality

As the FCC considers how to regulate Internet providers, the telecom industry’s stealth campaign for hearts and minds encompasses everything from art installations to LOLcats.


October 16 • 12:00 PM

How Many Ads Is Too Many Ads?

The conundrum of online video advertising.


October 16 • 11:00 AM

Unlocking Consciousness

A study of vegetative patients closes in on the nature of consciousness.


October 16 • 10:00 AM

The False Promises of Higher Education

Danielle Henderson spent six years and $60,000 on college and beyond. The effects of that education? Not as advertised.


October 16 • 8:00 AM

Faster Justice, Closer to Home: The Power of Community Courts

Community courts across the country are fighting judicial backlog and lowering re-arrest rates.


October 16 • 6:00 AM

Killing Your Husband to Save Yourself

Without proper legal instruments, women with abusive partners are often forced to make a difficult choice: kill or be killed.


October 16 • 4:00 AM

Personality Traits Linked to Specific Diseases

New research finds neurotic people are more likely to suffer a serious health problem.


October 16 • 2:00 AM

Comparing Apples to the Big Apple: Yes, Washington, D.C., Is More Expensive Than New York City

Why shouldn’t distant locales tied to jobs in the urban core count in a housing expenditure study?


October 15 • 4:00 PM

Why Asian American Parents Are the Least Likely to Spank Their Kids

Highly educated, middle-class parents are less likely to use corporal punishment to discipline their children than less-educated, working-class, and poor parents.


Follow us


Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they're motivated by love while their enemies are motivated by hate.

How to Water a Farm in Sandy Ground

Physicists investigate how to grow food more efficiently in fine-grained soil.

Unlocking Consciousness

A study of vegetative patients closes in on the nature of consciousness.

Advice for Emergency Alert Systems: Don’t Cry Wolf

A survey finds college students don't always take alerts seriously.

Brain’s Reward Center Does More Than Manage Rewards

Nucleus accumbens tracks many different connections in the world, a new rat study suggests.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.